GLP-1 weight loss and diabetes drugs linked to nutritional deficiencies in nearly 1 in 6 children
Wednesday, September 23, 2026Want headlines delivered to your inbox?
Subscribe to our free daily newsletter.
Children taking GLP-1 medications (such as Victoza, Saxenda, Trulicity, and Ozempic) for weight loss, prediabetes, or type 2 diabetes may face an overlooked risk: nutritional deficiencies. A new study found that nearly 1 in 6 young patients developed a diagnosed deficiency within a year of starting treatment, with vitamin D deficiency affecting about 12%. (via Science Daily)
Read the Full StoryThis article will expire in 28 days.
In the News...
View All Recent News
- Rare pregnancy infections may triple the risk of autism
- Breakthrough drug reverses skin aging and dramatically speeds healing
- GLP-1 weight loss and diabetes drugs linked to nutritional deficiencies in nearly 1 in 6 children
- More REM sleep linked to lower risk of 83 diseases
- This new drug could break cancer’s resistance to treatment
- Coffee doesn’t have to keep you awake to disrupt your sleep
- This emerging treatment could help people avoid knee replacement surgery
- Brain scans reveal a possible cause of long COVID fatigue and brain fog
- Stopping Ozempic may raise heart attack and stroke risk
- Stem cells reverse stroke damage and restore movement in mice
- Stanford scientists discover the human brain may actually be two separate organs
- Chronic stress may be quietly reshaping your heart
- Scientists create a needle-thin brain implant that can do three jobs at once
- Millions take calcium and vitamin D for bone health. A major review finds little benefit
- Ancient DNA reveals how plague kept returning for 400 years after the Black Death
- 8 common food additives linked to high blood pressure and heart disease
- Hidden gut defect that may explain why IBD keeps coming back
- Scientists solve a 50-year mystery and discover a new human blood group
- Scientists find that “perfect” systems may be surprisingly fragile
- A deadly ebola relative is surging after years in the shadows